Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Treasury Shares (2018 - 2025)

Historic Treasury Shares for Aytu Biopharma (AYTU) over the last 8 years, with Q4 2025 value amounting to $223088.0.

  • Aytu Biopharma's Treasury Shares rose 51538.12% to $223088.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $223088.0, marking a year-over-year increase of 51538.12%. This contributed to the annual value of $32912.0 for FY2025, which is 3653.6% up from last year.
  • According to the latest figures from Q4 2025, Aytu Biopharma's Treasury Shares is $223088.0, which was up 51538.12% from $31294.0 recorded in Q3 2025.
  • Aytu Biopharma's Treasury Shares' 5-year high stood at $2.2 million during Q4 2021, with a 5-year trough of $1786.0 in Q1 2021.
  • Moreover, its 5-year median value for Treasury Shares was $40675.5 (2022), whereas its average is $457300.4.
  • In the last 5 years, Aytu Biopharma's Treasury Shares crashed by 9994.66% in 2021 and then surged by 11957978.72% in 2022.
  • Aytu Biopharma's Treasury Shares (Quarter) stood at $2.2 million in 2021, then crashed by 98.0% to $43276.0 in 2022, then decreased by 12.36% to $37929.0 in 2023, then fell by 4.42% to $36252.0 in 2024, then soared by 515.38% to $223088.0 in 2025.
  • Its last three reported values are $223088.0 in Q4 2025, $31294.0 for Q3 2025, and $32912.0 during Q2 2025.